AllTrials: will it catch on in the US?
This article was originally published in Scrip
News that the AllTrials campaign has been launched in the US will be welcomed by transparency advocates. But it will be viewed with great disquiet by those in industry and elsewhere who are open to a degree of greater clinical trial disclosure but draw the line at releasing patient-level data.
You may also be interested in...
A number of countries are resorting to extreme measures such as export bans to preserve stocks of medicines for the COVID-19 pandemic. Belgium is among the latest to impose an export prohibition, but might it fall foul of the EU’s export regulations?
In addition to our daily in-depth coverage of key events relating to the COVID-19 pandemic, we’re bringing you a periodic round-up of other developments. This edition covers Europe and other countries.
The US company is bringing extra supplies of lopinavir/ritonavir into France but stresses that the combination treatment is not authorized for treating patients with the coronavirus.